|
Miltenyi Biotec
anti ccr6 antibodies ![]() Anti Ccr6 Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/bio_rxiv__64898__2026__03__02__708954-305-14-17?v=Miltenyi+Biotec Average 94 stars, based on 1 article reviews
anti ccr6 antibodies - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
fluidigm
resource source identifier anti human antibodies anti human ccr6 ![]() Resource Source Identifier Anti Human Antibodies Anti Human Ccr6, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/pm41916320-679-2-11?v=fluidigm Average 93 stars, based on 1 article reviews
resource source identifier anti human antibodies anti human ccr6 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
R&D Systems
monoclonal antibody against mouse fzd4 ![]() Monoclonal Antibody Against Mouse Fzd4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/pmc12750777-33-18-24?v=R%26D+Systems Average 94 stars, based on 1 article reviews
monoclonal antibody against mouse fzd4 - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
α human ccr6 pevio770 ![]() α Human Ccr6 Pevio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/pmc12670122-323-12-15?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
α human ccr6 pevio770 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd196 (ccr6) antibody, anti-mouse, reafinity ![]() Cd196 (Ccr6) Antibody, Anti Mouse, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/custom%40130-126-497%4041236926?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
cd196 (ccr6) antibody, anti-mouse, reafinity - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti human cd196 ccr6 apc ![]() Anti Human Cd196 Ccr6 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/pmc12592183-71-61-69?v=Miltenyi+Biotec Average 94 stars, based on 1 article reviews
anti human cd196 ccr6 apc - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Biorbyt
rabbit anti ccr6 ![]() Rabbit Anti Ccr6, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/pmc12506002-232-28-32?v=Biorbyt Average 93 stars, based on 1 article reviews
rabbit anti ccr6 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
ccr6 ![]() Ccr6, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ccr6+antibody/pm40845844-393-18-19?v=Miltenyi+Biotec Average 94 stars, based on 1 article reviews
ccr6 - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: Mapping the MIF-2 Chemokine Interactome Reveals MIF-2–CCL20 Complex Formation in Liver Fibrosis
doi: 10.64898/2026.03.02.708954
Figure Lengend Snippet: Shown are gene expression data re-analyzed from the GSE135251 dataset, focusing on CCL20, MIF, and MIF-2 (DDT) together with their corresponding receptors CCR6, CXCR4, and CD74 in NASH across increasing fibrosis stages (F0–F4; shades of magenta) compared with NAFL (grey) ( Govaere et al ., 2020 ). Statistical comparisons between groups were performed using the Mann–Whitney U test, with P values adjusted for multiple testing using the Holm–Bonferroni correction. NASH: non-alcoholic steatohepatitis; NAFL: non-alcoholic fatty liver disease. Statistical significance is indicated by actual adjusted P values.
Article Snippet: Antibodies included APC-conjugated anti-CXCR4 (BioLegend; Cat# 306510), FITC-conjugated anti-CD74 (BD Biosciences; Cat# 555540), and
Techniques: Gene Expression, MANN-WHITNEY
Journal: Biochemistry and Biophysics Reports
Article Title: Comparative analysis of activation of macrophages/microglia in diabetic retinopathy and Familial Exudative Vitreoretinopathy
doi: 10.1016/j.bbrep.2025.102396
Figure Lengend Snippet: FZD4 knockout mice develop FEVR features. FZD4 knockout mice (FZD4KO) was used as an FEVR model. (A) Western blot for FZD4 in the retinal tissue of FZD4 knockout mice, compared to wildtype controls (WT). (B–C) Electroretinogram (ERG) assessments at 16 weeks, shown by representative chars (B) and by quantification (C). Blue circle: b-wave; green circle: a-wave. (D) Retinal vascular density by CD31 + area quantification. N = 5. ∗p < 0.05. NS: no significant.
Article Snippet: Knockout of FZD4 in these mice were validated by Western blot for FZD4 in the retinal tissue, using
Techniques: Knock-Out, Western Blot
Journal: Life Science Alliance
Article Title: TRPM7 and magnesium orchestrate human CD4 T-cell activation and differentiation
doi: 10.26508/lsa.202503357
Figure Lengend Snippet: (A) Schematic description of naïve CD4 T-cell differentiation towards FOXP3-expressing regulatory T cells and RORƔt-expressing T H 17 cells, including respective cytokine polarization milieus. (B, C) Percentages of CD45RA − cells and (C) CD25 + CD127 lo cells upon polarization of naïve CD4 T cells toward iT reg cells in various NS8593 concentrations (red) compared with DMSO control (Ctrl, black), n = 6–7. (D, E) Representative FACS histograms and (E) quantification of FOXP3 expression levels of CD25 + CD127 lo iT reg cells upon 6 d polarization of naïve CD4 T cells in presence of various NS8593 concentrations (red) or DMSO control (Ctrl, black), n = 6–7. (F, G) Percentages of CD45RA − cells and (G) CD25 + CD127 lo cells upon polarization of naïve CD4 T cells toward iT reg cells in presence of 6 mM MgCl 2 (MgCl 2 , blue) compared with H 2 O control (Ctrl, black), n = 7. (H, I) Representative FACS histograms and (I) quantification of FOXP3 expression levels of CD25 + CD127 lo iT reg cells upon 6 d polarization of naïve CD4 T cells in presence of 6 mM MgCl 2 (MgCl 2 , blue) compared with H 2 O control (Ctrl, black), n = 6. (J) Percentages of CCR6 + cells upon polarization of naïve CD4 T cells towards iT H 17 cells in presence of various NS8593 concentrations (red) compared with DMSO control (Ctrl, black), n = 6. (K, L) Representative FACS histograms and (L) quantification of RORƔt expression levels of CCR6 + iT H 17 cells upon 6 d polarization of naïve CD4 T cells in presence of various NS8593 concentrations (red) or DMSO control (Ctrl, black), n = 4–6. (M) Percentages of CCR6 + cells upon polarization of naïve CD4 T cells towards iT H 17 cells in presence of 6 mM MgCl 2 (MgCl 2 , blue) compared with H 2 O control (Ctrl, black), n = 6. (N, O) Representative FACS histograms and (O) quantification of RORƔt expression levels of CCR6 + iT H 17 cells upon 6 d polarization of naïve CD4 T cells in presence of 6 mM MgCl 2 (MgCl 2 , blue) compared with H 2 O control (Ctrl, black), n = 5. (P) Graphical summary of TRPM7-(in)dependent T-cell activation and differentiation towards iT reg and iT H 17 cells. Pharmacological blockade of TRPM7 reduces intracellular Mg 2+ levels, leads to reduced Ca 2+ signaling and results in reduced IL-2 secretion, impaired up-regulation of T-cell activation markers CD69 and CD25, and diminished proliferation upon TCR stimulus (left). TRPM7 inhibition during polarization of naïve CD4 T cells into iT reg cells preserves FOXP3 + signals of CD25 + CD127 lo iT reg cells. Polarization of naïve CD4 T cells into iT H 17 cells results in augmented RORƔt expression in the presence of 6 mM Mg 2+ , which is reduced upon TRPM7 inhibition, highlighting the need for Mg 2+ uptake and related TRPM7-dependent intracellular signaling for iT H 17 cell polarization (right). (B, C, E, F, G, I, J, L, M, O) Statistics: one-way ANOVA (B, C, E, J, L) and t test (F, G, I, M, O). * P < 0.05; ** P < 0.005; *** P < 0.0005; **** P < 0.0001 and n.s., not significant. Data are mean ± SD.
Article Snippet: Surface staining was performed using the following antibodies: α-human CD25-PE (BC96; BioLegend),
Techniques: Cell Differentiation, Expressing, Control, Activation Assay, Inhibition
Journal: Life Science Alliance
Article Title: TRPM7 and magnesium orchestrate human CD4 T-cell activation and differentiation
doi: 10.26508/lsa.202503357
Figure Lengend Snippet: (A) Representative FACS plots and gating strategy for iT H 17 cells after 6 d of differentiation of naïve CD4 T cells, shown for Ctrl cells. Naïve CD4 T cells were used for gating. (B) Percentage of viable cells upon polarization of naïve CD4 T cells toward T H 17 cells in various NS8593 concentrations (red) compared with DMSO control (Ctrl, black), gated as in (A), n = 6. (C) Percentage of viable cells upon polarization of naïve CD4 T cells towards T H 17 cells in presence of 6 mM MgCl 2 (MgCl 2, blue) compared with H 2 O control (Ctrl, black), gated as in (A), n = 6. (D, E, F) Percentages of viable cells (D), CCR6 + cells (E) and RORƔt expression (F) upon polarization of naïve CD4 T cells toward T H 17 cells in presence of 1 μM Apamin (Apamin, blue) compared with DMSO control (Ctrl, gray), gated as in (A), n = 5–6. (B, C, D, E, F) Statistics: one-way ANOVA (B) and t test (C, D, E, F). **** P < 0.0001 and n.s., not significant. Data are mean ± SD.
Article Snippet: Surface staining was performed using the following antibodies: α-human CD25-PE (BC96; BioLegend),
Techniques: Control, Expressing